Flutamide in hormone-resistant prostatic cancer

SD Fosså, G Hosbach, E Paus - The Journal of urology, 1990 - Elsevier
Abstract Flutamide (250 mg. orally 3 times daily) yielded a subjective response in 5 of 25
fully evaluable patients with hormone-resistant prostatic cancer. Four additional patients had …
被引用次数：34 相关文章

Flutamide in Hormone-Resistant Prostatic Cancer

SD Fosså, G Hosbach, E Paus - The Journal of Urology, 1990 - auajournals.org
Abstract Flutamide (250mg. orally 3 times daily) yielded a subjective response in 5 of 25 fully
evaluable patients with hormone-resistant prostatic cancer. Four additional patients had …

Flutamide in hormone-resistant prostatic cancer.

SD Fosså, G Hosbach, E Paus - The Journal of Urology, 1990 - europepmc.org
Flutamide (250 mg. orally 3 times daily) yielded a subjective response in 5 of 25 fully
evaluable patients with hormone-resistant prostatic cancer. Four additional patients had …

Flutamide in hormone-resistant prostatic cancer

SD Fosså, G Hosbach, E Paus - The Journal of urology, 1990 - pubmed.ncbi.nlm.nih.gov
Flutamide (250 mg. orally 3 times daily) yielded a subjective response in 5 of 25 fully
evaluable patients with hormone-resistant prostatic cancer. Four additional patients had …

[引用][C] Flutamide in hormone-resistant prostatic cancer

SD FOSSA, G HOSBACH, E PAUS - The Journal of urology, 1990 - pascal-francis.inist.fr
Flutamide in hormone-resistant prostatic cancer CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …

[引用][C] Flutamide in hormone-resistant prostatic cancer

SD FOSSA, G HOSBACH, E PAUS - The Journal of urology, 1990 - Elsevier

[引用][C] FLUTAMIDE IN HORMONE-RESISTANT PROSTATIC CANCER

SD FOSSA, G HOSBACH, E PAUS - The Journal of urology, 1990 - Elsevier